Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime?

Current hematologic malignancy reports - 1 Mar 2015

Sucheston-Campbell Lara E, Clay Alyssa, McCarthy Philip L, Zhu Qianqian, Preus Leah, Pasquini Marcelo, Onel Kenan, Hahn Theresa

Abstract excerpt

Overall survival following hematopoietic cell transplantation (HCT) has improved over the past two decades through better patient selection and advances in HLA typing, supportive care, and infection prophylaxis. Nonetheless, mortality rates are still unsatisfactory and transplant-related mortality remains a major cause of death after unrelated allogeneic HCT. Since there are no known pre-HCT, non-HLA biologic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Graft vs Host Disease
Share to Hematologic Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Histocompatibility Testing

Share to HLA Antigens

Share to Receptors, KIR

Share to Tissue Donors

Share to Transplant Recipients

Share to Transplantation, Homologous

Source

Open in PubMed Open full text

Identifiers

PMID: 25700678
DOI: 10.1007/s11899-014-0246-x
PMCID: PMC4352187

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime?PMID 25700678Read ↗

Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation.Semantic proximity Read ↗

Non-HLA genomics: does it have a role in predicting haematopoietic stem cell transplantation outcome?Semantic proximity Read ↗

Haematopoietic stem cell transplantation: can our genes predict clinical outcome?Semantic proximity Read ↗

MHC-resident variation affects risks after unrelated donor hematopoietic cell transplantation.Semantic proximity Read ↗

Patient HLA Germline Variation and Transplant Survivorship.Semantic proximity Read ↗

Single nucleotide polymorphisms and outcome risk in unrelated mismatched hematopoietic stem cell transplantation: an exploration study.Semantic proximity Read ↗

Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantationSemantic proximity Read ↗

Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant.Semantic proximity Read ↗

Risk assessment in haematopoietic stem cell transplantation: pre-transplant patient and donor factors: non-HLA genetics.Semantic proximity Read ↗

Non-HLA genetics and predicting outcome in HSCT.Semantic proximity Read ↗

Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation.Semantic proximity Read ↗

Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters MostSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.